Your browser doesn't support javascript.
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry.
Gimeno, Juan R; Olivotto, Iacopo; Rodríguez, Ana Isabel; Ho, Carolyn Y; Fernández, Adrián; Quiroga, Alejandro; Espinosa, Mari Angeles; Gómez-González, Cristina; Robledo, María; Tojal-Sierra, Lucas; Day, Sharlene M; Owens, Anjali; Barriales-Villa, Roberto; Larrañaga, Jose María; Rodríguez-Palomares, Jose; González-Del-Hoyo, Maribel; Piqueras-Flores, Jesús; Reza, Nosheen; Chumakova, Olga; Ashley, Euan A; Parikh, Victoria; Wheeler, Matthew; Jacoby, Daniel; Pereira, Alexandre C; Saberi, Sara; Helms, Adam S; Villacorta, Eduardo; Gallego-Delgado, María; de Castro, Daniel; Domínguez, Fernando; Ripoll-Vera, Tomás; Zorio-Grima, Esther; Sánchez-Martínez, José Carlos; García-Álvarez, Ana; Arbelo, Elena; Mogollón, María Victoria; Fuentes-Cañamero, María Eugenia; Grande, Elias; Peña, Carlos; Monserrat, Lorenzo; Lakdawala, Neal K.
  • Gimeno JR; Departamento de Medicina Interna, Universidad de Murcia, Ctra. Finca Buenavista s/n, Campus Ciencias de la Salud, El Palmar, Murcia, 30120, Spain.
  • Olivotto I; European Reference Networks for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Amsterdam, The Netherlands.
  • Rodríguez AI; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Ho CY; Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
  • Fernández A; Departamento de Medicina Interna, Universidad de Murcia, Ctra. Finca Buenavista s/n, Campus Ciencias de la Salud, El Palmar, Murcia, 30120, Spain.
  • Quiroga A; European Reference Networks for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Amsterdam, The Netherlands.
  • Espinosa MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Gómez-González C; Unidad de Cardiopatías Familiares, Favaloro Foundation University Hospital, Buenos Aires, Argentina.
  • Robledo M; Unidad de Cardiopatías Familiares, Favaloro Foundation University Hospital, Buenos Aires, Argentina.
  • Tojal-Sierra L; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Day SM; Unidad de Cardiopatías Familiares, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Owens A; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Barriales-Villa R; Unidad de Cardiopatías Familiares, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Larrañaga JM; Hospital Universitario Araba (Txagorritxu), Alava, Spain.
  • Rodríguez-Palomares J; Hospital Universitario Araba (Txagorritxu), Alava, Spain.
  • González-Del-Hoyo M; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Piqueras-Flores J; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Reza N; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Chumakova O; Unidad CSUR Cardiopatías Familiares, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Ashley EA; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Parikh V; Unidad CSUR Cardiopatías Familiares, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Wheeler M; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Jacoby D; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Pereira AC; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Saberi S; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Helms AS; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Villacorta E; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Gallego-Delgado M; Cardiac Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • de Castro D; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Domínguez F; Municipal Clinical Hospital #17, Moscow, Russia.
  • Ripoll-Vera T; Center for Inherited Heart Disease, Stanford University Medical Center, Stanford, CA, USA.
  • Zorio-Grima E; Center for Inherited Heart Disease, Stanford University Medical Center, Stanford, CA, USA.
  • Sánchez-Martínez JC; Center for Inherited Heart Disease, Stanford University Medical Center, Stanford, CA, USA.
  • García-Álvarez A; Yale New Haven Hospital, New Haven, CT, USA.
  • Arbelo E; Hospital das Clinicas da Univerisidade de Sao Paulo, Sao Paulo, Brazil.
  • Mogollón MV; Department of Internal Medicine, University of Michigan Hospital, Ann Arbor, MI, USA.
  • Fuentes-Cañamero ME; Department of Internal Medicine, University of Michigan Hospital, Ann Arbor, MI, USA.
  • Grande E; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
  • Peña C; Unidad de Cardiopatías Familiares, Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
  • Monserrat L; Gerencia Regional de Salud de Castilla y León (SACYL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
  • Lakdawala NK; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
ESC Heart Fail ; 9(4): 2189-2198, 2022 08.
Article in English | MEDLINE | ID: covidwho-1881405
ABSTRACT

AIMS:

To describe the natural history of SARS-CoV-2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events. METHODS AND

RESULTS:

Three hundred and five patients [age 56.6 ± 16.9 years old, 191 (62.6%) male patients] with HCM and SARS-Cov-2 infection were enrolled. The control group consisted of 91 131 infected individuals. Endpoints were (i) SARS-CoV-2 related mortality and (ii) severe clinical course [death or intensive care unit (ICU) admission]. New onset of atrial fibrillation, ventricular arrhythmias, shock, stroke, and cardiac arrest were also recorded. Sixty-nine (22.9%) HCM patients were hospitalized for non-ICU level care, and 21 (7.0%) required ICU care. Seventeen (5.6%) died eight (2.6%) of respiratory failure, four (1.3%) of heart failure, two (0.7%) suddenly, and three (1.0%) due to other SARS-CoV-2-related complications. Covariates associated with mortality in the multivariable were age {odds ratio (OR) per 10 year increase 2.25 [95% confidence interval (CI) 1.12-4.51], P = 0.0229}, baseline New York Heart Association class [OR per one-unit increase 4.01 (95%CI 1.75-9.20), P = 0.0011], presence of left ventricular outflow tract obstruction [OR 5.59 (95%CI 1.16-26.92), P = 0.0317], and left ventricular systolic impairment [OR 7.72 (95%CI 1.20-49.79), P = 0.0316]. Controlling for age and sex and comparing HCM patients with a community-based SARS-CoV-2 cohort, the presence of HCM was associated with a borderline significant increased risk of mortality OR 1.70 (95%CI 0.98-2.91, P = 0.0600).

CONCLUSIONS:

Over one-fourth of HCM patients infected with SARS-Cov-2 required hospitalization, including 6% in an ICU setting. Age and cardiac features related to HCM, including baseline functional class, left ventricular outflow tract obstruction, and systolic impairment, conveyed increased risk of mortality.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atrial Fibrillation / Cardiomyopathy, Hypertrophic / Ventricular Dysfunction, Left / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: ESC Heart Fail Year: 2022 Document Type: Article Affiliation country: Ehf2.13964

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Atrial Fibrillation / Cardiomyopathy, Hypertrophic / Ventricular Dysfunction, Left / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: ESC Heart Fail Year: 2022 Document Type: Article Affiliation country: Ehf2.13964